Michael Johnson, MD
Interventional Cardiology · New Rochelle, NYNPI 1356352397
Payments from drug & device makers
Across 311 payments — averaging $200.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$53K
- Abiomed$2K
- Boston Scientific$2K
- Medtronic$1K
- Shockwave Medical, Inc$1K
- Cardiovascular Systems Inc.$493
- plus $2K from 9 others
What the payments were for
- Consulting fees$2502%
- Travel & lodging$70%
- Food & beverage$10,44198%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 102 | $53,328 |
| Abiomed | 81 | $2,310 |
| Boston Scientific | 44 | $2,110 |
| Medtronic(2 entities) | 21 | $1,437 |
| Shockwave Medical, Inc | 21 | $1,002 |
| Cardiovascular Systems Inc. | 20 | $493 |
| Terumo Medical Corporation | 3 | $451 |
| Edwards Lifesciences | 6 | $428 |
| Spectrawave, Inc | 4 | $369 |
| Asahi Intecc USA, Inc. | 2 | $179 |
| Johnson & Johnson | 2 | $41 |
| Philips North America LLC | 1 | $36 |
| Novartis | 2 | $33 |
| Teleflex LLC | 1 | $28 |
| Bridgebio Pharma, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$874
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$705
- Optis Coronary Imaging System$513
- AVVIGO Guidance System$469
- HyperVue Imaging System$346
- Starlight Imaging Catheter$346
- ONYX FRONTIER$315
- OPTIS$290
- Coronary Orbital Atherectomy System$272
- CoreValve Evolut$262
- PASCAL$259
- GlideWire$250
- Heartrail$201
- ASAHI PTCA Guide Wire$175
- Launcher$170
- ROTAPRO$168
- Perclose ProGlide suture mediated closure system$166
- WOLVERINE$149
- GENERAL - STENTS$147
- Mitra Clip system$145
How this compares
$62,262 in reported general payments places this provider in the 75th percentile of 382 interventional cardiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 12 | $262 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 25 | $143 |
| Amlodipine Besylate | 16 | $88 |
| Metoprolol Succinate | 12 | $57 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in New Rochelle
- Martin LeonNew York$13.5M
- David CohenRoslyn$9.8M
- Susheel KodaliNew York$6M
- Mohamed Azeem LatibBronx$4.6M
- Richard ShlofmitzRoslyn$4.5M
- Deepak BhattNew York$4.1M
- Samin SharmaNew York$3.7M
- Annapoorna KiniNew York$3.5M
- Sahil ParikhNew York$2.7M
- George DangasNew York$2.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.